Literature DB >> 17097577

GnRH analogs: options for endometriosis-associated pain treatment.

Frances R Batzer1.   

Abstract

While none of the currently available treatment options for endometriosis pain resolved the underlying disease process, there are growing numbers of medical alternatives available. Medical options include the GnRH agonists and antagonists. Review of these treatments in the management of endometriosis pain and the insight often to the etiology of endometriosis are presented for discussion.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17097577     DOI： 10.1016/j.jmig.2006.07.007

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN： 1553-4650            Impact factor:   4.137


  11 in total

1.  Treatment of Endometriosis and Chronic Pelvic Pain with Letrozole and Norethindrone Acetate.

Authors:  S Chawla
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Oral continuous combined 0.5 mg estradiol valerate and 5 mg dydrogesterone as daily add-back therapy during post-operative GnRH agonist treatment for endometriosis in Chinese women.

Authors:  Shien Zou; Qiqi Long; Shaofen Zhang; Yi Han; Wei Zhang
Journal:  Int J Clin Exp Med       Date:  2012-11-30

Review 3.  Endometriosis: current therapies and new pharmacological developments.

Authors:  Paolo Vercellini; Edgardo Somigliana; Paola Viganò; Annalisa Abbiati; Giussy Barbara; Pier Giorgio Crosignani
Journal:  Drugs       Date:  2009       Impact factor: 9.546

4.  Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density.

Authors:  Bruce Carr; W Paul Dmowski; Chris O'Brien; Ping Jiang; Joshua Burke; Roland Jimenez; Elizabeth Garner; Kristof Chwalisz
Journal:  Reprod Sci       Date:  2014-09-23       Impact factor: 3.060

5.  Inflammatory status influences aromatase and steroid receptor expression in endometriosis.

Authors:  Orhan Bukulmez; Daniel B Hardy; Bruce R Carr; R Ann Word; Carole R Mendelson
Journal:  Endocrinology       Date:  2007-11-29       Impact factor: 4.736

6.  Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment.

Authors:  Felice Petraglia; Daniela Hornung; Christian Seitz; Thomas Faustmann; Christoph Gerlinger; Stefano Luisi; Lucia Lazzeri; Thomas Strowitzki
Journal:  Arch Gynecol Obstet       Date:  2011-06-17       Impact factor: 2.344

7.  Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management.

Authors:  Bernice Tsoi; Gord Blackhouse; Simon Ferrazzi; Clare J Reade; Innie Chen; Ron Goeree
Journal:  Clinicoecon Outcomes Res       Date:  2015-04-17

8.  Effect of neuromuscular electrical stimulation for endometriosis-associated pain: A retrospective study.

Authors:  Xue-Ling Bi; Cai-Xia Xie
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

9.  Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study.

Authors:  Bruce Carr; Linda Giudice; W Paul Dmowski; Chris O'Brien; Ping Jiang; Joshua Burke; Roland Jimenez; Steven Hass; Mahesh Fuldeore; Kristof Chwalisz
Journal:  J Endometr Pelvic Pain Disord       Date:  2013-07-13

10.  Severe ovarian hyperstimulation syndrome associated with long-acting GnRH agonist in oncofertility patients.

Authors:  Jacob Christ; Christopher N Herndon; Bo Yu
Journal:  J Assist Reprod Genet       Date:  2021-01-20       Impact factor: 3.412
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.